Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care    FME   DE0005785802

FRESENIUS MEDICAL CARE (FME)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 04/25 07:16:22 pm
81.05 EUR   -2.09%
04/24FRESENIUS MEDIC : wins Red Dot design award for advanced bloodline s..
PU
04/23Jilted Akorn sues Fresenius over deal termination
RE
04/23Jilted Akorn sues Fresenius over deal termination
RE
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
04/19/2018 04/20/2018 04/23/2018 04/24/2018 04/25/2018 Date
85.04(c) 84.88(c) 81.32(c) 82.78(c) 81.06 Last
432 092 573 371 1 461 303 1 120 948 678 613 Volume
+0.19% -0.19% -4.19% +1.80% -2.08% Change
More quotes
Financials (EUR)
Sales 2018 17 594 M
EBIT 2018 2 502 M
Net income 2018 1 322 M
Debt 2018 6 883 M
Yield 2018 1,32%
Sales 2019 19 219 M
EBIT 2019 2 768 M
Net income 2019 1 480 M
Debt 2019 6 435 M
Yield 2019 1,48%
P/E ratio 2018 19,19
P/E ratio 2019 17,43
EV / Sales2018 1,82x
EV / Sales2019 1,64x
Capitalization 25 056 M
More Financials
Company
Fresenius Medical Care AG & Co. KGaA provides products and services for patients with chronic kidney failure.The company's products include dialysis machines, dialyzers and related disposables.It also offers renal information technology solutions and provides services such as renal replacement... 
More about the company
Surperformance© ratings of Fresenius Medical Care
Trading Rating : Investor Rating :
More Ratings
Latest news on FRESENIUS MEDICAL CARE
04/24FRESENIUS MEDICAL CARE : wins Red Dot design award for advanced bloodline system..
PU
04/23Jilted Akorn sues Fresenius over deal termination
RE
04/23Jilted Akorn sues Fresenius over deal termination
RE
04/23FRESENIUS MEDICAL CARE : Sells Sound Inpatient Physicians Holdings
DJ
04/23FRESENIUS MEDICAL CARE : Reduces Growth Target, Posts 1Q Net Profit Loss
DJ
04/22Fresenius pulls out of Akorn takeover over data integrity
RE
04/22FRESENIUS MEDICAL CARE : cuts 2018 sales target after drug dosage shift
RE
04/22FRESENIUS MEDICAL CARE : confirms net income growth target, adjusts 2018 revenue..
EQ
04/22FRESENIUS MEDICAL CARE : Adjusts Its 2018 Revenue Growth Target And Confirms Its..
DJ
04/22AD HOC : Fresenius Medical Care adjusts its 2018 revenue growth target and confi..
PU
More news
Sector news : Healthcare Facilities & Services - NEC
04/24Malaysia's IHH Sends Updated Proposal to Buy India's Fortis Healthcare
DJ
04/23Akorn, Inc. Sues Fresenius For Consummation Of Merger Agreement After Its Ter..
DJ
04/23Jilted Akorn sues Fresenius over deal termination
RE
04/23Jilted Akorn sues Fresenius over deal termination
RE
04/23AKORN : Fresenius says will not renegotiate after cancelling Akorn deal
RE
More sector news : Healthcare Facilities & Services - NEC
4-Traders Strategies on FRESENIUS MEDICAL CARE 
FRESENIUS MEDICAL CARE - 04/10
No turn-around in sight
BUY
FRESENIUS MEDICAL CARE - 03/22
Underpinned by a support level
BUY
More Strategies
Latest Tweets
08:46aDZ Bank Reiterates Buy Rating for Fresenius Medical Care $FMS  
08:25a$FRE - DZ Bank Reaffirms Buy Rating for Fresenius SE & Co KGaA #FRE  
04/24? Recap | Fresenius pulls out of Akorn takeover over data integrity  
04/24$FME Medical Care AG Co. KGaA Fresenius Medical Care AG Co. KGaA: The sales .. 
04/24Morning EU Movers: AMS does not compute! SAP +2.9% BAE Systems +1.5% Fresen..
6
More tweets
Qtime:81
News from SeekingAlpha
04/23Treasury Yields Head Towards 3%, While Flipkart Investors Await Walmart's Off.. 
04/23WALL STREET BREAKFAST : 10-Year Treasury Yield Flirts With 3% 
04/23Akorn takes issue with Fresenius' planned exit from merger 
04/22Fresenius divests Sound Inpatient for $2B 
04/11ROAD TO FINANCIAL INDEPENDENCE : My March 89-Stock Portfolio Review 
Chart FRESENIUS MEDICAL CARE
Duration : Period :
Fresenius Medical Care Technical Analysis Chart | FME | DE0005785802 | 4-Traders
Technical analysis trends FRESENIUS MEDICAL CARE
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 92,7 €
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Rice Powell Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Michael Brosnan Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Dieter Schenk Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS MEDICAL CARE-5.70%30 605
HCA HOLDINGS (HOSPITAL CORPORATION AMERICA)10.31%34 324
LABORATORY CORPORATION OF AMERICA HOLDINGS3.55%16 848
QUEST DIAGNOSTICS0.97%13 332
DAVITA-12.68%11 603
UNIVERSAL HEALTH SERVICES5.99%11 367